Cullen/Frost Bankers’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-149
Closed -$7.67K 1218
2023
Q1
$7.67K Buy
+149
New +$7.23K ﹤0.01% 975
2021
Q4
Sell
-388
Closed -$21K 1265
2021
Q3
$21K Hold
388
﹤0.01% 963
2021
Q2
$24K Buy
+388
New +$20.6K ﹤0.01% 953

Other funds holding LMAT

Cullen/Frost Bankers's LMAT Position: Q2 2023 in Review

Cullen/Frost Bankers sold out of LeMaitre Vascular (LMAT) in Q2 2023, closing a stake of 149 shares — an estimated $7.67K sold.

Cullen/Frost Bankers first reported a position in LMAT in Q2 2021 and held it in 3 quarters. The position peaked at $24K in Q2 2021. 212 funds tracked by Wall St. Rank hold LMAT as of Q2 2023.

  • Cullen/Frost Bankers reported no remaining LeMaitre Vascular position as of Q2 2023 after selling out during the quarter.
  • Cullen/Frost Bankers sold 149 LeMaitre Vascular shares in Q2 2023, an estimated $7.67K.
  • Cullen/Frost Bankers first reported a position in LeMaitre Vascular in Q2 2021 and held it in 3 quarters.
  • Cullen/Frost Bankers's LeMaitre Vascular position peaked at $24K in Q2 2021.
  • 212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2023.

Based on Cullen/Frost Bankers's 13F filing for Q2 2023, filed 4 Aug 2023.